Health News

How do Pain Medications Relate to Alzheimers?
In a large Canadian study, researchers found that people who took certain types of pain medications were less likely to develop Alzheimer’s Disease, but it is not clear why.
Potential Dangers of Multiple Sclerosis Treatment
The U.S. Food and Drug Administration is alerting health care professionals and patients about injuries and death associated with the use of an experimental procedure sometimes called “liberation therapy” or the “liberation procedure” to treat chronic cerebrospinal venous insufficiency ( CCSVI ).
Slowing Brain Activity
Mild cognitive impairment (MCI) is a loss of thinking skills that increases risk of Alzheimer’s Disease. Areas of the brain are overactive in MCI, and new research shows that lowering the activity may improve memory. Higher levels of brain activity in the hippocampus, a brain region important for memory, are common in MCI. Using a drug to lower that brain activity led to better memory function for patients with MCI. Consult your physician if you notice any memory problems MCI is a loss of thinking and memory abilities that is more severe than normal aging and less severe than ...
Avoiding Alzheimer’s With Purpose
Purpose in life can be as simple as having a hobby or connecting with family. New research points to having purpose in life to keep memory and thinking going strong.
Alzheimer’s Drug Does not Relieve Agitation
A new study shows that Namenda ( memantine ), used in the treatment of Alzheimer’s Disease (AD), does not improve agitation symptoms. As AD progresses, agitation is a common symptom that often appears as restlessness, anxiousness, or becoming easily upset. A recent study looked at this aspect, specifically, and found that Namenda did not appear to offer any benefit to these symptoms. Talk with a doctor if a loved one with AD experiences agitation The study, led by Chris Fox, MD, of the University of East Anglia in the United Kingdom, enrolled 149 patients with AD who also ...
Pfizer Stops Phase 3 Trial Of Lyrica
Pfizer Inc. announced that it has stopped a Phase 3 clinical trial of Lyrica ( pregabalin ) in patients with neuropathic pain associated with HIV neuropathy, a form of nerve damage characterized by burning pain usually beginning in the feet.
Pfizer Reports Subpar Lyrica Phase 3 Results
Pfizer Inc. announced that a Phase 3 randomized withdrawal design study for Lyrica ( pregabalin ) in patients with inadequately treated painful diabetic peripheral neuropathy ( pDPN ) did not meet its primary efficacy endpoint.
Onset Age of Alzheimer’s may Predict Symptoms
Alzheimer’s disease is typically divided into two categories: early onset and late onset. New research shows that the specific types of deficits experienced may be related to the type or onset age of the disorder.
Spotting Spinal Arthritis Early
Ankylosing spondylitis is not the most common cause of back pain. As such, it might be over-the-top to screen every back pain patient for ankylosing spondylitis . So, how can doctors more easily spot those with the disease?
Nuts May Help Your Noggin
Have an extra slice of salmon each week, or add some almonds to your weekly snacks - it may help keep your mind clearer for longer as you get on in years. A recent study has found a link between eating foods with omega-3 fatty acids and lower levels of a protein that's related to Alzheimer's disease. Foods like fish, nuts and chicken are sources of omega-3s . Regularly eat foods with omega-3 fatty acids, like chicken and nuts. lead author Nikolaos Scarmeas , MD, of Columbia University Medical Center in New York, and colleagues set out to find connections between specific nutrie...